Beth Israel Med Ctr-Cardio is categorized under Medical Centers in Newark, NJ and active since 2002.
Beth Israel Med Ctr-Cardio was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Bob Iannaccone, Vice President at the company’s single location by writing to 201 Lyons Avenue, Newark, New Jersey NJ 07112 or by phoning (973) 926-7747. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Beth Israel Med Ctr-Cardio |
| Contact Person: | Bob Iannaccone, Vice President |
| Address: | 201 Lyons Avenue, Newark, New Jersey 07112 |
| Phone Number: | (973) 926-7747 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6219992 |
| Share This Business: |
Beth Israel Med Ctr-Cardio was started in 2002 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Bob Iannaccone, Vice President for inquiries that concern Beth Israel Med Ctr-Cardio by calling the company number (973) 926-7747, as your correspondence is most welcome. Additionally, the physical location of the single location of Beth Israel Med Ctr-Cardio can be found at the coordinates 40.71029,-74.21411 as well as the street address 201 Lyons Avenue in Newark, New Jersey 07112.
For its online presence, you may visit Beth Israel Med Ctr-Cardio’s website at and engage with its social media outlets through on Twitter and on Facebook.